Evidence map›Paper›PMID 36246872›Full record

ArticleFrontiers in endocrinology2022

Identification of hub genes for early detection of bone metastasis in breast cancer.

Zitong Zhao, Haoran Yang, Guangling Ji, Shanshan Su, Yuqi Fan, Minghao Wang, Shengli Gu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. FPR2 Agonism Attenuates Restenosis by Mitigating Neointimal Hyperplasia via ELOVL6.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zitong ZhaoDepartment of Geriatrics, Zhabei Central Hospital, Jing'an District, Shanghai, China.
Haoran YangDepartment of Geriatrics, Zhabei Central Hospital, Jing'an District, Shanghai, China.
Guangling JiDepartment of Geriatrics, Zhabei Central Hospital, Jing'an District, Shanghai, China.
Shanshan SuDepartment of Geriatrics, Zhabei Central Hospital, Jing'an District, Shanghai, China.
Yuqi FanDepartment of Geriatrics, Zhabei Central Hospital, Jing'an District, Shanghai, China.
Minghao WangDepartment of Geriatrics, Zhabei Central Hospital, Jing'an District, Shanghai, China.
Shengli GuDepartment of Geriatrics, Zhabei Central Hospital, Jing'an District, Shanghai, China.
Shanghai Zhabei District Shibei Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Globally, among all women, the most frequently detected and diagnosed and the most lethal type of cancer is breast cancer (BC). In particular, bone is one of the most frequent distant metastases 24in breast cancer patients and bone metastasis arises in approximately 80% of advanced patients. Thus, we need to identify and validate early detection markers that can differentiate metastasis from non-metastasis breast cancers. Methods: GSE55715, GSE103357, and GSE146661 gene expression profiling data were downloaded from the GEO database. There was 14 breast cancer with bone metastasis samples and 8 breast cancer tissue samples. GEO2R was used to screen for differentially expressed genes (DEGs). The volcano plots, Venn diagrams, and annular heatmap were generated by using the ggplot2 package. By using the cluster Profiler R package, KEGG and GO enrichment analyses of DEGs were conducted. Through PPI network construction using the STRING database, key hub genes were identified by cytoHubba. Finally, K-M survival and ROC curves were generated to validate hub gene expression. Results: By GO enrichment analysis, 143 DEGs were enriched in the following GO terms: extracellular structure organization, extracellular matrix organization, leukocyte migration class II protein complex, collagen tridermic protein complex, extracellular matrix structural constituent, growth factor binding, and platelet-derived growth factor binding. In the KEGG pathway enrichment analysis, DEGs were enriched in Staphylococcus aureus infection, Complement and coagulation cascades, and Asthma. By PPI network analysis, we selected the top 10 genes, including SLCO2B1, STAB1, SERPING1, HLA-DOA, AIF1, GIMAP4, C1orf162, HLA-DMB, ADAP2, and HAVCR2. By using TCGA and THPA databases, we validated 2 genes, SERPING1 and GIMAP4, that were related to the early detection of bone metastasis in BC. Conclusions: 2 abnormally expressed hub genes could play a pivotal role in the breast cancer with bone metastasis by affecting bone homeostasis imbalance in the bone microenvironment.

Indexed as

Bone NeoplasmsBreast NeoplasmsComplement C1 Inhibitor ProteinComputational BiologyEarly Detection of CancerFemaleGene Expression Regulation, NeoplasticGTP-Binding ProteinsHumansIntercellular Signaling Peptides and ProteinsPlatelet-Derived Growth FactorTumor MicroenvironmentComplement C1 Inhibitor ProteinGIMAP4 protein, humanGTP-Binding ProteinsIntercellular Signaling Peptides and ProteinsPlatelet-Derived Growth Factorbioinformatics analysisbone homeostasis imbalancebone microenvironmentbreast cancer with bone metastasisHub genesimmunostaining

Identifiers

PMID36246872
PMCPMC9556899
OpenAlexW4298003873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.